Results 231 to 240 of about 141,477 (341)

The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db mice

iScience
Summary: Clopidogrel has been shown to play a protective role against diabetic nephropathy. However, whether clopidogrel exerts a protective effect against diabetic cardiomyopathy (DCM) is unknown.
Bing Li, Yaoting Zhang, Yang Zheng, He Cai   +3 more
doaj  

Ticagrelor versus clopidogrel in <i>CYP2C19</i> loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy. [PDF]

Ren Fail
Wu Y, Zhou Y, Pan Y, Jin A, Meng X, Li H, Wang Y, Jiang Y, Wang Y.   +8 more
europepmc   +1 more source

Haemorrhage Associated with Combined Clopidogrel and Aspirin Therapy

, 2001
Todd Chapman, Douglas M. Bowley, A W Lambert, Andrew Walker, S. Ashley, David C. Wilkins   +5 more
openalex   +1 more source

Fatal toxic bone marrow failure associated with Clopidogrel [PDF]

, 2003
Jens Chemnitz, D. Söhngen, Armin Schulz, Volker Diehl, Christof Scheid   +4 more
openalex   +1 more source

Promoting resilience to weather‐related and seasonal provocations to health in people with multimorbid heart disease: a prospective pragmatic, randomised trial

Medical Journal of Australia, Volume 223, Issue 2, Page 77-84, July 2025.
Abstract Objective To investigate whether a multifaceted intervention for building resilience to external provocations to health reduced the number of all‐cause hospital re‐admissions and deaths of people hospitalised with multimorbid heart disease, compared with standard post‐discharge management.
Simon Stewart, Sheila K Patel, Terase F Lancefield, Thalys Sampaio Rodrigues, Nicholas Doumtsis, Nasreen Moini, Ashleigh Harley, Emily‐Rose Vaughan‐Fowler, Yih‐Kai Chan, Alexander Chen, David Chye, David FL Liew, Christopher McMaster, Jay Ramchand, Paul A Yates, Jason C Kwong, Christine F McDonald, Louise M Burrell   +17 more
wiley   +1 more source

Stasis Ulcers Refractory to Therapy—Accelerated Healing by Treatment With Clopidogrel ± Dalteparin: A Preliminary Report

, 2001
Rodger L. Bick, Ronald G. Scott
openalex   +1 more source

A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications. [PDF]

NPJ Genom Med
Shorbaji A, Pushparaj PN, Al-Ghafari AB, Mira LS, Basabrain MA, Naseer MI, Ahmed F, Abu-Elmagd M, Rasool M, Bakhashab S.   +9 more
europepmc   +1 more source

PCV2: COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL COMPARED WITH TICLOPIDINE IN THROMBOSIS PREVENTION

, 2001
P Vorobiov, З. С. Баркаган, M Avxentieva, V Gerasimov, М. В. Сура, E.V. Derkach   +5 more
openalex   +1 more source

Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures [PDF]

, 2003
T. Ramesh Kumar Rao, P.R. Usha, M.U.R. Naidu, Jaideep Gogtay, Matthew Meena   +4 more
openalex   +1 more source

PCV8: COST-EFFECTIVENESS OF CLOPIDOGREL COMPARED WITH TICLOPIDINE IN THROMBOSIS PREVENTION: DECISION ANALYSIS TAKING INTO ACCOUNT SIDE-EFFECTS

, 2001
P Vorobiov, З. С. Баркаган, M Avxentieva, V Gerasimov, М. В. Сура, E.V. Derkach   +5 more
openalex   +1 more source